The Journal of Physical Chemistry Letters,
Journal Year:
2024,
Volume and Issue:
unknown, P. 12129 - 12137
Published: Nov. 27, 2024
It
is
a
critical
and
broad
prospect
to
evaluate
ion
levels
monitor
their
dynamic
changes
in
the
brain
for
early
diagnosis,
in-depth
mechanism
investigation,
accurate
staging
of
neurodegenerative
diseases
including
Alzheimer's
disease
(AD).
still
great
challenge
vivo
track
Zn
Journal of the American Chemical Society,
Journal Year:
2025,
Volume and Issue:
147(2), P. 2010 - 2020
Published: Jan. 7, 2025
Developing
small
organic
molecular
phototheranostic
agents
with
second
near-infrared
(NIR-II)
aggregation-induced
emission
(AIE)
is
paramount
for
the
phototriggered
diagnostic
imaging
and
synchronous
in
situ
therapy
of
cancer
via
an
excellent
balance
excited
states
energy
dissipations.
In
this
study,
a
multifunctional
iridium(III)
complex
exploited
by
coordination
AIE-active
N^N
ancillary
ligand
trivalent
iridium
ion.
The
resultant
DPTPzIr
significantly
outperforms
its
parent
terms
absorption/emission
wavelengths,
reactive
oxygen
species
(ROS)
production,
photothermal
conversion,
which
simultaneously
endow
nanoparticles
matched
absorption
peak
to
commercial
808
nm
laser,
longest
NIR-II
(above
1100
nm)
among
those
previously
reported
AIE
complexes,
potentiated
type-I
ROS
generation,
as
high
60.5%
conversion
efficiency.
Consequently,
perform
well
multimodal
image-guided
photodynamic
therapy-photothermal
breast
tumor-bearing
mice,
enabling
precise
tumor
diagnosis
complete
ablation
biocompatibility.
Our
present
work
provides
simple,
feasible,
effective
paradigm
development
advanced
agents.
Nano Letters,
Journal Year:
2024,
Volume and Issue:
24(27), P. 8287 - 8295
Published: June 28, 2024
Organic
dyes
with
simultaneously
boosted
near-infrared-II
(NIR-II)
fluorescence,
type
I
photodynamic
therapy
(PDT),
and
photothermal
(PTT)
in
the
aggregate
state
are
still
elusive
due
to
unclear
structure-function
relationship.
Herein,
electron-withdrawing
substituents
introduced
at
5-indolyl
positions
of
BODIPY
form
tight
J-aggregates
for
enhanced
NIR-II
fluorescence
PDT/PTT.
The
introduction
an
electron-rich
julolidine
group
ACS Nano,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 4, 2024
Constructing
J-aggregated
organic
dyes
represents
a
promising
strategy
for
obtaining
biomedical
second
near-infrared
(NIR-II)
emissive
materials,
as
they
exhibit
red-shifted
spectroscopic
properties
upon
assembly
into
nanoparticles
(NPs)
in
aqueous
environments.
However,
currently
available
NIR-II
J-aggregates
primarily
rely
on
specific
molecular
backbones
with
intricate
design
strategies
and
are
susceptible
to
fluorescence
quenching
during
assembly.
A
facile
approach
constructing
bright
using
prevalent
donor-acceptor
(D-A)
molecules
is
still
lacking.
In
this
study,
we
present
method
that
transforms
D-A
by
simply
bending
the
molecule
through
introducing
methyl
group,
enabling
high-performance
phototheranostics.
The
TAA-BT-CN
exhibits
hypsochromic-shift
absorption
forming
H-aggregated
NPs,
while
designed
mTAA-BT-CN
bent
structure
demonstrates
bathochromic
shift
of
over
100
nm
leading
much
enhanced
emission
beyond
1100
nm.
With
respect
its
counterpart
aggregation-caused
(ACQ)
phenomenon,
NPs
7-fold
increase
owing
their
aggregation-induced
(AIE)
property
well
efficient
generation
heat
reactive
oxygen
species
under
808
light
excitation.
Finally,
employed
whole-body
blood
vessel
imaging
technology
imaging-guided
tumor
phototherapies.
This
study
will
facilitate
flourishing
advancement
based
D-A-type
molecules.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(33)
Published: March 19, 2024
Complete
removal
of
all
tumor
tissue
with
a
wide
surgical
margin
is
essential
for
the
treatment
osteosarcoma
(OS).
However,
it's
difficult,
sometimes
impossible,
to
achieve
due
invisible
small
satellite
lesions
and
blurry
boundaries.
Besides,
intraoperative
frozen-section
analysis
resection
margins
OS
often
restricted
by
hard
tissues
around
OS,
which
makes
it
impossible
know
whether
negative
achieved.
Any
unresected
residuals
will
lead
local
recurrence
worse
prognosis.
Herein,
based
on
high
expression
B7H3
in
targeted
probe
B7H3-IRDye800CW
synthesized
conjugating
anti-B7H3
antibody
IRDye800CW.
can
accurately
label
areas
after
intravenous
administration,
thereby
helping
surgeons
identify
resect
residual
(<2
mm)
lung
metastatic
lesions.
The
tumor-background
ratio
reaches
4.42
±
1.77
at
day
3.
After
incubating
fresh
human
specimen
B7H3-IRDye800CW,
specifically
area
even
microinvasion
(confirmed
hematoxylin-eosin
[HE]
staining).
labeled
consistent
shown
magnetic
resonance
imaging
complete
HE
staining
specimen.
In
summary,
has
translational
potential
guidance
rapid
pathological
diagnosis
OS.
Journal of Medicinal Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 13, 2025
Glioblastoma
(GBM)
is
the
most
lethal
form
of
malignant
brain
tumor,
known
for
its
high
infiltration,
aggressiveness,
and
poor
prognosis.
Second
near-infrared
(NIR-II,
1000-1700
nm)
phototheranostic
agents
bring
intriguing
opportunities
GBM
management
owing
to
their
noninvasive
nature,
controllability,
deeper
tissue
penetration.
Herein,
an
amphiphilic
NIR-II
luminogen
(PEG-TD)
with
aggregation-induced
emission
(AIE)
characteristics,
along
hydrophobic
counterpart
(C6-TD),
was
meticulously
synthesized.
Specifically,
PEG-TD
nanoparticles
(NPs),
formed
through
straightforward
self-assembly,
exhibited
superior
stability,
simplicity,
robust
reactive
oxygen
species
production
efficiency,
excellent
photothermal
conversion
compared
C6-TD
NPs,
which
were
fabricated
via
coassembly
DSPE-mPEG,
primarily
attributed
distinct
molecular
arrangements
within
forming
aggregates.
The
inherent
advantages
NPs
led
significant
therapeutic
efficacy
against
GL261
cells
under
808
nm
laser
irradiation.
Eventually,
fluorescence/photothermal
duplex
imaging-guided
combined
photodynamic/photothermal
therapy
successfully
performed
in
orthotopic
glioblastoma
mouse
model
minimal
adverse
effects.